Complementary and Alternative Medicine Approaches in Alzheimer Disease and Other Neurocognitive Disorders

Mo Med. 2023 Jan-Feb;120(1):70-78.

Abstract

As our population ages, there is interest in delaying or intervening in cognitive decline. While newer agents are under development, agents in mainstream use do not impact the course of diseases that cause cognitive decline. This increases interest in alternative strategies. Even as we welcome possible new disease-modifying agents, they are likely to remain costly. Herein, we review the evidence behind other complementary and alternative strategies for cognitive enhancement and prevention of cognitive decline.

Publication types

  • Review

MeSH terms

  • Alzheimer Disease* / therapy
  • Cognitive Dysfunction* / therapy
  • Complementary Therapies*
  • Humans
  • Neurocognitive Disorders